Thyrocare Technologies Limited has announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported a standalone profit of ₹48.13 crore for the quarter, with total revenue from operations standing at ₹256.25 crore. The consolidated results also indicate a net profit of ₹15.22 crore for the quarter.
Thyrocare Technologies Reports Q2 FY27 Financials
Thyrocare Technologies Limited has disclosed its unaudited standalone financial results for the quarter and half-year that concluded on September 30, 2026. The Board of Directors, at its meeting held on October 29, 2026, considered and approved these results.
Standalone Financial Highlights
For the quarter ended September 30, 2026, Thyrocare Technologies reported a profit after tax of ₹48.13 crore. The revenue from operations for the same period was ₹256.25 crore, with total revenue (including other income) amounting to ₹259.19 crore. Total expenses for the quarter were ₹184.19 crore.
The profit for the half-year ended September 30, 2026, stood at ₹98.30 crore. Total revenue for the six months reached ₹488.36 crore, while total expenses were ₹346.73 crore.
Consolidated Financial Overview
On a consolidated basis, the profit for the quarter ended September 30, 2026, was ₹15.22 crore. Consolidated revenue from operations for the quarter was ₹270.81 crore, with total consolidated revenue at ₹274.44 crore. Total consolidated expenses were ₹196.61 crore.
For the six-month period ended September 30, 2026, the consolidated profit was ₹66.55 crore. Consolidated revenue from operations for this period was ₹510.83 crore, and total consolidated revenue was ₹518.61 crore. Total consolidated expenses amounted to ₹373.20 crore.
Key Operational Details
The Board Meeting commenced at 2:35 P.M. and concluded at 03:42 P.M. on October 29, 2026. The financial results, along with the Limited Review Reports from the Statutory Auditors, have been attached as Annexure A and are available on the company’s investor website.
Source: BSE
